{
    "eid": "2-s2.0-85131523729",
    "title": "The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma",
    "cover-date": "2022-05-17",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "acquired vulnerability",
        "CDK4/6 inhibitor",
        "cholangiocarcinoma (CCA)",
        "oxaliplatin",
        "palbociclib",
        "ribosomal biogenesis stress"
    ],
    "authors": [
        "Orawan Suppramote",
        "Sunisa Prasopporn",
        "Satinee Aroonpruksakul",
        "Ben Ponvilawan",
        "Jiradej Makjaroen",
        "Monthira Suntiparpluacha",
        "Krittiya Korphaisarn",
        "Komgrid Charngkaew",
        "Rawisak Chanwat",
        "Trairak Pisitkun",
        "Seiji Okada",
        "Somponnat Sampattavanich",
        "Siwanon Jirawatnotai"
    ],
    "citedby-count": 4,
    "ref-count": 35,
    "ref-list": [
        "Chemotherapy and Targeted Therapy in Advanced Biliary Tract Carcinoma: A Pooled Analysis of Clinical Trials",
        "Cholangiocarcinoma - Evolving Concepts and Therapeutic Strategies",
        "Exome Sequencing Identifies Frequent Inactivating Mutations in BAP1, ARID1A and PBRM1 in Intrahepatic Cholangiocarcinomas",
        "Exome Sequencing Identifies Distinct Mutational Patterns in Liver Fluke-Related and Non-Infection-Related Bile Duct Cancers",
        "Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma",
        "Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma",
        "Genomic Spectra of Biliary Tract Cancer",
        "Mutational Landscape of Intrahepatic Cholangiocarcinoma",
        "Cholangiocarcinoma 2020: The Next Horizon in Mechanisms and Management",
        "Dependency of Cholangiocarcinoma on Cyclin D-Dependent Kinase Activity",
        "A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition",
        "Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Suppresses Cholangiocarcinoma Growth by Targeting CDK2/5/9",
        "Palbociclib in Patients With Pancreatic and Biliary Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study",
        "CDK4/6 Inhibitors: Promising Opportunities Beyond Breast Cancer",
        "An Acquired Vulnerability of Drug-Resistant Melanoma With Therapeutic Potential",
        "Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer",
        "BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models",
        "Perturbation of 60 S Ribosomal Biogenesis Results in Ribosomal Protein L5- and L11-Dependent P53 Activation",
        "Comprehensive Proteomics Identification of IFN-Lambda3-Regulated Antiviral Proteins in HBV-Transfected Cells",
        "Organoid Models of Human Liver Cancers Derived From Tumor Needle Biopsies",
        "Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition",
        "How Common are Extraribosomal Functions of Ribosomal Proteins",
        "Ribosomal Proteins: Functions Beyond the Ribosome",
        "The Role of Ribosomal Proteins in the Regulation of Cell Proliferation, Tumorigenesis, and Genomic Integrity",
        "Silencing Expression of Ribosomal Protein L26 and L29 by RNA Interfering Inhibits Proliferation of Human Pancreatic Cancer PANC-1 Cells",
        "Endogenous Ribosomal Protein L29 (RPL29): A Newly Identified Regulator of Angiogenesis in Mice",
        "Repression of HIP/RPL29 Expression Induces Differentiation in Colon Cancer Cells",
        "HIP/RPL29 Down-Regulation Accompanies Terminal Chondrocyte Differentiation",
        "MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-Resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors",
        "Regulation of HDM2 Activity by the Ribosomal Protein L11",
        "Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a P53-Dependent Ribosomal-Stress Checkpoint Pathway",
        "Inhibition of MDM2-Mediated P53 Ubiquitination and Degradation by Ribosomal Protein L5",
        "CDK4/6 Inhibitors: What Is the Best Cocktail",
        "Ribosome Biogenesis and Cell Growth: mTOR Coordinates Transcription by All Three Classes of Nuclear RNA Polymerases",
        "Overlapping Functions of the pRb Family in the Regulation of rRNA Synthesis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "60029487",
            "affilname": "National Cancer Institute Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029487",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022464",
            "affilname": "Chulabhorn Royal Academy",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022464",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kumamoto",
            "@id": "60021120",
            "affilname": "Kumamoto University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021120",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Advanced Research in Pharmacology Fund",
        "Foundation for Cancer Care",
        "Siriraj Research Fund",
        "National Institute of Allergy and Infectious Diseases",
        "Siriraj Foundation",
        "Japan Science and Technology Agency",
        "National Science and Technology Development Agency",
        "Thailand Research Fund",
        "Siriraj Hospital"
    ]
}